Prefilament tau species as potential targets for immunotherapy for Alzheimer disease and related disorders

Rakez Kayed, George R. Jackson

Research output: Contribution to journalReview article

42 Scopus citations


Alzheimer disease (AD) is the most common neurodegenerative disorder. Currently available therapies may slow cognitive decline but do not alter underlying disease processes. Considerable effort over the last decade has been directed toward the development of vaccines for AD; these have been primarily directed against the Aβ peptide, a component of senile plaques. More recently, alternative approaches have begun to target the microtubule binding protein tau, a component of neurofibrillary tangles. Immunotherapies based upon oligomeric species of tau represent a promising new approach for AD.

Original languageEnglish (US)
Pages (from-to)359-363
Number of pages5
JournalCurrent Opinion in Immunology
Issue number3
StatePublished - Jun 1 2009


ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this